Kanenori Endo

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

Kanenori Endo, Byung–Il Yoon, Chawalit Pairojkul et al. · Hepatology · 2002 · 188 citations · Full text

Human Cholangiocarcinoma, Risk Conditions, Immunology +24

Immunoreactive e-cadherin, alpha-catenin,beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival

Kanenori Endo, Tsuyoshi Ueda, Junichi Ueyama et al. · Human Pathology · 2000 · 180 citations

Hepatology, Tumor Grade, Immunoreactive E-cadherin +8

Protein expression of CD44 (standard and variant isoforms) in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, p53 expression, and patient survival

Kanenori Endo, Tadashi Terada · Journal of Hepatology · 2000 · 164 citations

Tumor Biology, Oncology, Hepatology +12

Cyclooxygenase-2 and ERBB-2 in Cholangiocarcinoma: Potential Therapeutic Targets

Alphonse E. Sirica, Guan‐Hua Lai, Kanenori Endo et al. · Seminars in Liver Disease · 2002 · 88 citations

Tumor Biology, Potential Therapeutic Targets, Human Cholangiocarcinogenesis +14

Protein expression of MDM2 and its clinicopathological relationships in human hepatocellular carcinoma

Kanenori Endo, Tsuyoshi Ueda, Tetsuo Ohta et al. · Liver International · 2000 · 52 citations